Figure 3 shows CCRL1 is significantly lower in luminal B compared to triple negative breast cancer samples. High ACKR4/CCRL1 expression correlated with worse survival in patients with triple negative or basal tumors (Fig. 9D). This evidence concerns the gene CX3CR1 and triple-negative breast carcinoma.